Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 7, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on August 4, 2006:
- Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("GSK Trust"), transferred 3,000 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- The Company was advised of these transactions on August 7, 2006.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Consequently, three directors—Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop—hold an interest in the shares held in the GSK Trust in the same manner as other employees. The notification was made in accordance with Disclosure Rule 3.1.4R(1)(b). No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares held by the GSK Trust to assess the significance of the 3,000-share transfer.
- Confirm the specific identities of the employees who received the shares under the SmithKline Beecham Employee Share Option Plan 1991.
- Review the company's broader annual report (Form 20-F) for comprehensive financial metrics, as this filing contains none.